Buyers complain about server errors, allege discounts were 'not real'.
In an email to customers they say 'Big Billion Day' sale today to eclipse all other multi-day festive sales.
At the very least, it will cost Infosys thousands of dollars to defend its position
Industry insiders expect Chinese tourists coming to India to double in around two years.
'Big Billion Day' scheduled for October 6 is inspired by flat number where co-founders began their journey.
The chief executive of the e-commerce giant is making his second visit to India -- the first since Amazon entered this market.
It all started with Flipkart and Amazon trying to outdo each other - after Flipkart announced $1-billion fund-raising in July.
Seems to reflect a maturing of the segment; Delhi-based Wingify buys US-based entity a day after Zomato's Polish buyout
While iPhone 6 and iPhone 6 Plus are being sold at $199-499 (Rs 12,100-30,400) with a two-year contract in the US, buyers in India are purchasing these at the grey market for a whopping Rs 100,000-200,000.
Retail giants are looking at Indian start-ups in the big data and analytics space
Proposed investment dip 33% from Rs 1.42 lakh crore (Rs 1.42 trillion) in 2011 to Rs 94,259 crore (Rs 942.59 billion) in 2013
Company to set up task force to implement 2,000-plus ideas it has received.
After spending time at several of the company's delivery locations in India over the past week and holding town hall discussions with employees, on Monday Sikka wrote to the company's staff seeking their views on how to improve Infosys.
Company identifies areas like cognitive technologies, artificial intelligence, man-machine interface, robotics
Twenty-year-old Ripal Prajapati had to settle for mailing a 'rakhi' to her god-brother this time around.
The creation of the Amul brand and its famous mascot gave a rural revolution a durable competitive edge.
In an email interview with Business Standard, Mindtree's co-founder and chairman says the company was designed to outlive the founding team and no such departure is a loss.
Analysts say no pressure on new CEO for immediate results.
It has replacements ready even for senior managers, in case someone quits.
Sun Pharma to retain these in most markets; US could be the exception, where the Ranbaxy name has taken a hit.